Effect of lung metastasis on the treatment and prognosis of patients with gestational trophoblastic neoplasia: A systematic review and meta-analysis. [PDF]
Zhang T +6 more
europepmc +1 more source
Severe methotrexate hypersensitivity during treatment for Gestational trophoblastic Neoplasia: Case Report and considerations for management. [PDF]
Kar A, Mills KA.
europepmc +1 more source
Case report: Multidrug resistant gestational trophoblastic neoplasia: focus on failure of immunotherapy and success of high-dose chemotherapy. [PDF]
Enuset A +4 more
europepmc +1 more source
Clinical features and demographic characteristics of gestational trophoblastic neoplasia: Single center experience and the SEER database. [PDF]
Hou YM +8 more
europepmc +1 more source
Risk factors for methotrexate resistance in low-risk gestational trophoblastic neoplasia patients (FIGO score 0-4). [PDF]
Jin T +13 more
europepmc +1 more source
Immunotherapy for Gestational Trophoblastic Neoplasia: A New Paradigm.
Baas IO +5 more
europepmc +1 more source
Related searches:
Gestational Trophoblastic Neoplasia
Obstetrics & Gynecology, 2008To report the results of treatment of gestational trophoblastic neoplasia (GTN) at the John I. Brewer Trophoblastic Disease Center over the past 28 years, compare the outcomes to those from the first 16 years, and analyze factors affecting response to treatment and survival.We reviewed the records of 408 patients with GTN (excluding placental-site ...
Anna V, Hoekstra +3 more
+5 more sources
Gestational Trophoblastic Neoplasia
Obstetrics and Gynecology Clinics of North America, 2012Trophoblastic neoplasms are a truly fascinating set of diseases that arise from a failed gestation. A molar pregnancy is an allograft of fetal tissue typically containing only paternal chromosomes that may invade the maternal decidua following a failed gestation that may have arisen up to decades earlier.
R, Osborne, J, Dodge
openaire +2 more sources
GESTATIONAL TROPHOBLASTIC NEOPLASIA
Clinical Obstetrics and Gynecology, 1974This review covers the development of chemotherapeutic treatment during the past 25 years for gestational trophoblastic neoplasia; there is now a cure rate of 80% of the cases of hydatiform mole invasive mole and choriocarcinoma. The clinician pathologist investigator will have the prime role in future breakthroughs as he has had in the preceeding ...
openaire +2 more sources

